EPAS1 and breast carcinoma: Results of the study on breast cancer cell lines suggest the need to consider aspects like HIF-1α versus HIF-2α inhibition, double versus singular isoform inhibition, different hormone receptors status, metastases, and perhaps different not yet investigated issues.